The emotional architecture of the psychedelic brain
Flora Moujaes, Nathalie M. Rieser, L. Belinger, Marcus Herdener, Zarmeen Zahid, Katrin H. Preller
Trends in Cognitive Sciences August 18, 2025 DOI: 10.1016/j.tics.2025.07.006 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Keywords | Cognitive science Architecture Cognitive psychology Visual arts |
| Citations | 5 |
| Key findings | Psychedelics' effects on emotional processing may play a central role in their therapeutic potential, but more precise characterization of emotional states and temporal dynamics is needed. |
Abstract
Serotonergic psychedelics are being explored as treatments for a range of psychiatric conditions. Promising results in mood disorders indicate that their effects on emotional processing may play a central role in their therapeutic potential. However, mechanistic and clinical studies paint a complex picture of the impact of psychedelics on emotions and mood. Here, we review recent findings on the effects of psychedelics on emotion, emotional empathy, and mood. We discuss how psychedelics may impact long-term emotion management strategies, the significance of challenging experiences, and neuroplastic changes. More precise characterization of emotional states and greater attention to the temporal dynamics of psychedelic-induced effects will be critical for clarifying their mechanisms of action and optimizing their therapeutic impact.
Citations in the library
Cited by 4
- Psychedelics for treatment of negative symptoms and depressive symptoms in schizophrenia spectrum disorder: A narrative review Schizophrenia Research March 13, 2026
- Multimodal autonomic arousal tracks dose-dependent affective dynamics during the acute effects of DMT bioRxiv May 4, 2026
- Holding space between notes: Music, silence, and cultural attunement in psychedelic-assisted therapy Psychedelics April 2, 2026
- Investigating Emotional Reactivity in Experienced Users of Psychedelics: A Cross‐Sectional fMRI Study Human Brain Mapping April 1, 2026
Cites 93
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology July 7, 2006
- Trial of Psilocybin versus Escitalopram for Depression New England Journal of Medicine April 14, 2021
- Psychedelics Promote Structural and Functional Neural Plasticity Cell Reports June 1, 2018
- Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression. New England Journal of Medicine November 3, 2022
and 88 more in the library